|
Drug discovery isn't just another outsourcing
business for Crown Biosciences--it's a source of new
technology and predictive strategies that may speed
drugs to market. As a dedicated outsourcing company,
we strongly believe in the value of creating customized
solutions to meet specific needs. Crown Bio’s
business model is unique to the industry as we:
- Focusing on preclinical biology
services
- Accelerate R&D in a timely
and cost-effective fashion
- No internal product development
pipeline
- Data neutrality
- No conflict of interest
Engagement options at Crown Bio
guarantees cost effective entry options throughout our
drug development pipeline process, including:
|
Project based model
- Specific projects with clearly defined process and endpoint
- Short term engagement
- Renewable 12-month engagement
- Model development
- Cost savings in Predictive plat
|
Program based model
- From lead to IND candidate
- Integrated service package
- Accelerated project lines
- Customized Expertise
- Final deliverables IND ready
|
|
FTE based model
- Dedicated research team
- Choose the Expertise Your Project needs
- Huge Resource Savings
|
Strategic Alliance model
- Sliding scale Risk-sharing
- Lower upfront FTE cost
- Success payment after achieving certain milestones
- Exclusive access to proprietary
|
|
